Florida is poised to have another shot at legalizing adult-use cannabis, reigniting hopes that the US’s third most populous state
US cannabis industry revenues are set to grow just 3.2% in 2025, as price compression, difficult economic dynamics and an increasingly complex political landscape put the brakes on the sector.Â
Florida’s medical cannabis industry is set to almost double, dismantling the monopoly 28 companies have held since 2017 in one of the US’s largest markets.Â
US cannabis companies have endured a significant selloff in the days following the results of the election, seeing $2.6bn wiped off their collective market capitalization.Â
Cannabis stocks plunge on election results As the outcome of the US presidential election and numerous state-specific cannabis ballots dripped
Beyond the presidential result, yesterday key cannabis reform votes took place across numerous states, poised to have a significant impact
As the most consequential US election in recent history comes to close after a long and turbulent campaign, the dust is beginning to settle on the prospective outlook for cannabis under the new administration.Â
If approved by voters on Tuesday, new regulated adult-use marijuana markets in Florida and North Dakota – along with a medical cannabis market in Nebraska – could collectively produce $3 billion during the first full year of sales.
November is set to be a critical month for cannabis legalization efforts in the US, with four states placing key cannabis reforms on the ballot.Â
As Florida prepares to vote on Amendment 3, which would legalize adult-use cannabis in the state, Florida’s largest medical cannabis
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
